JP2024508925A5 - - Google Patents

Info

Publication number
JP2024508925A5
JP2024508925A5 JP2023553678A JP2023553678A JP2024508925A5 JP 2024508925 A5 JP2024508925 A5 JP 2024508925A5 JP 2023553678 A JP2023553678 A JP 2023553678A JP 2023553678 A JP2023553678 A JP 2023553678A JP 2024508925 A5 JP2024508925 A5 JP 2024508925A5
Authority
JP
Japan
Prior art keywords
composition according
pathogen
agent
protein
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023553678A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024508925A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/018125 external-priority patent/WO2022187132A1/en
Publication of JP2024508925A publication Critical patent/JP2024508925A/ja
Publication of JP2024508925A5 publication Critical patent/JP2024508925A5/ja
Pending legal-status Critical Current

Links

JP2023553678A 2021-03-04 2022-02-28 人畜共通感染症の処置及び予防のためのワクチン Pending JP2024508925A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163156645P 2021-03-04 2021-03-04
US63/156,645 2021-03-04
US202163246580P 2021-09-21 2021-09-21
US63/246,580 2021-09-21
PCT/US2022/018125 WO2022187132A1 (en) 2021-03-04 2022-02-28 Vaccines for the treatment and prevention of zoonotic infections

Publications (2)

Publication Number Publication Date
JP2024508925A JP2024508925A (ja) 2024-02-28
JP2024508925A5 true JP2024508925A5 (enExample) 2025-02-13

Family

ID=83116733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023553678A Pending JP2024508925A (ja) 2021-03-04 2022-02-28 人畜共通感染症の処置及び予防のためのワクチン

Country Status (5)

Country Link
EP (1) EP4301406A4 (enExample)
JP (1) JP2024508925A (enExample)
CA (1) CA3212672A1 (enExample)
WO (1) WO2022187132A1 (enExample)
ZA (1) ZA202309263B (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US10004799B2 (en) * 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2772267B1 (en) * 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
CA3167081A1 (en) * 2020-02-06 2021-08-12 Luke T. Daum Immunogenic compositions to treat and prevent microbial infections

Similar Documents

Publication Publication Date Title
Finco et al. Designing vaccines for the twenty-first century society
ES2214511T3 (es) Procedimiento para mejorar la inmunogenicidad de un compuesto inmunogenico o de un hapteno y aplicacion para la preparacion de vacunas.
US20240166697A1 (en) Immunogenic Compositions to Treat and Prevent Microbial Infections
JP2008530245A5 (enExample)
JP2015536134A5 (enExample)
CN104203272A (zh) 复合抗原序列及疫苗
JP2023503058A (ja) ヘモフィルス・パラスイスに対する新規ワクチン
JP2024508925A5 (enExample)
CN113226361A (zh) 疫苗多肽组合物及方法
Verfaillie et al. Priming of piglets against enterotoxigenic E. coli F4 fimbriae by immunisation with FAEG DNA
JP2005082581A (ja) 分泌型IgA抗体誘導剤
Gupta et al. Role of microbes in production of vaccines
CN101448522A (zh) 包含蛋白质nmb0938的药物组合物
US12485166B2 (en) Vaccines for the treatment and prevention of zoonotic infections
US20240123055A1 (en) Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
US20250304627A1 (en) Immunogenic Compositions to Treat and Prevent Microbial Infections
US20240050552A1 (en) Vaccines for the treatment and prevention of seasonal and emerging infections
US20240091331A1 (en) Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
US12403189B2 (en) Immunogenic antigens
TWI912376B (zh) 減毒之豬流行性下痢病毒
Božić et al. An overview of current vacccines for the prophylaxis of bacterical infections Pres
RU2757013C2 (ru) Рекомбинантная противогриппозная вакцина с широким спектром защиты и способ ее получения
CA3212672A1 (en) Vaccines for the treatment and prevention of zoonotic infections
Parnham opments in vaccinology will be outlined.
Lina Efficiency Evaluation of 5BT, a Genetically Recombinant Multi-epitope-protein, for Its Application as a Subunit Vaccine against Foot and Mouth Disease